May, 2025

article thumbnail

Master the Sales Process: Closing Deals Effectively

Integrity Solutions

For most deals today, sellers aren’t just facing off against their competitors; they’re also battling a potential “no decision” scenario. In fact, some studies have shown that between 40% and 60% of deals wither on the vine, failing to close even after the customer expressed an intent to purchase. At the same time, buying cycles have grown longer and more complex, bogging down deal velocity and creating more opportunities for a buyer to reconsider or put off a decision

article thumbnail

AI in Clinical Settings: Balancing Innovation, Patient Care, and Personalized Medicine

MedCity News

AI addresses the disconnect between recommended guidelines and action by increasing engagement with personalized, actionable education and updates at appropriate times, The post AI in Clinical Settings: Balancing Innovation, Patient Care, and Personalized Medicine appeared first on MedCity News.

Medicine 308
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A startup with Theranos ties has another blood test in the works. This time, competition is waiting.

PharmaVoice

A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — an area where other companies are already making strides.

article thumbnail

The One Conversation Missing from ASCO: The Crushing Cost of Cancer Drugs

World of DTC Marketing

Each year, the American Society of Clinical Oncology (ASCO) meeting brings together the brightest minds in cancer research, pharmaceuticals, and patient care to share breakthroughs, data, and hope. And each year, one glaring topic remains conspicuously under-discussed: the brutal, life-altering cost of cancer treatment. We celebrate new therapies. We hear about remarkable survival data.

Insurance 208
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

FDA tightens heart tox warnings on mRNA COVID vaccines

pharmaphorum

The FDA has instructed Pfizer and Moderna to add stronger warnings to the labels of their COVID-19 vaccines about the risk of cardiotoxicity

FDA 136

More Trending

article thumbnail

Medical Sales Secrets: Win All The Doctors, Increase Your Sales

Evolve Your Success

Unfiltered Medical Sales: Why Doctors Buy You Before the Product Ready to elevate your medical sales game? In the final episode of our Unfiltered Medical Sales mini series, seasoned expert Todd Crowder shares his top strategies for mastering client interactions and building lasting relationships. From choosing the right setting for a meeting to reading the emotional cues of your audience, Todd breaks down the art of creating connection wh

article thumbnail

Americans’ Trust in the Healthcare System Is Plummeting. How Can It Be Repaired?

MedCity News

Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to prioritize empathy, transparency and personalized communication. The post Americans Trust in the Healthcare System Is Plummeting. How Can It Be Repaired? appeared first on MedCity News.

article thumbnail

Lilly’s former small molecule head makes the leap to a rising biotech in obesity

PharmaVoice

Utpal Singh joined the peptide-focused biotech Zealand Pharma last month after it notched a massive obesity deal with Roche.

Pharma 179
article thumbnail

HHS cancels $766m bird flu vaccine contract with Moderna

Pharmaceutical Technology

The HSS has terminated a contract previously awarded to Moderna to help advance a vaccine candidate targeting bird flu.

111
111
article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

UK trumpets £1bn investment plan from BioNTech

pharmaphorum

BioNTech has said it will commit up to 1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector

106
106
article thumbnail

MHRA approves guselkumab for Crohn’s disease and ulcerative colitis

PharmaTimes

Regulator confirms safety and efficacy of new treatment option for patient

Safety 113
article thumbnail

Why Medical Device Sales? Unlock Your Power, Make a Difference

Evolve Your Success

Why Medical Device Sales? Unlock Your Power, Make a Difference If you’re looking for a career that combines high earning potential with the opportunity to make a real impact, medical device sales could be the perfect fit. In this fast- paced, dynamic industry, sales professionals help healthcare providers find the best tools and technologies to improve patient care.

Sales 130
article thumbnail

Eli Lilly Commits $1B to Get Drug That Could Rival Vertex’s New Non-Opioid Pain Med

MedCity News

Eli Lillys acquisition of SiteOne Therapeutics acquisition comes ahead of Phase 2 testing of the startups lead drug candidate, which blocks the NaV1.8 sodium channel to treat pain. This target has clinical and regulatory validation from the recent FDA approval of Vertex Pharmaceuticals pain drug, Journavx. The post Eli Lilly Commits $1B to Get Drug That Could Rival Vertexs New Non-Opioid Pain Med appeared first on MedCity News.

article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Is pharma ready to let go of animal testing?

PharmaVoice

Regulators have signaled their willingness to embrace alternative tests and guide the industry in new directions.

Pharma 194
article thumbnail

Sanofi buys Vigil Neuroscience for $470m in Alzheimer’s push

Pharmaceutical Technology

Sanofi has agreed to acquire Vigil Neuroscience in a $470m deal, nearly a year after investing an initial $40m in the company.

95
article thumbnail

World first as infant gets personalised CRISPR therapy

pharmaphorum

In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation

Medical 99
article thumbnail

Herantis Pharma doses final cohort in phase 1b trial of HER-096 for Parkinson’s disease

PharmaTimes

Trial progresses towards topline data expected later in the year

Pharma 113
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

New technology could enhance CAR T therapy manufacture

European Pharmaceutical Review

Research has illustrated a potential new device for harvesting T cells that could improve the cost-effectiveness of manufacturing CAR T-cell therapy and make the cancer immunotherapy more accessible to patients. In development by investigators in the US, the device, called capture and glow (CAPGLO), captures T cells via a magnetic field and makes them visible using glowing fluorescent tags.

article thumbnail

23andMe Bankruptcy Auction Win Adds Big Piece to Regeneron’s Gene-Based Drug R&D Efforts

MedCity News

Regeneron Pharmaceuticals $256 million offer was chosen the winner of 23andMes bankruptcy auction. Drug research never became a big part of the genetic testing companys business, but it is getting a new life by joining Regeneron Genetics Center, a Regeneron subsidiary that analyzes genetic data for drug R&D. The post 23andMe Bankruptcy Auction Win Adds Big Piece to Regeneron’s Gene-Based Drug R&D Efforts appeared first on MedCity News.

article thumbnail

With the third round of Medicare price negotiations on the way, here’s how the policy is shifting

PharmaVoice

HHS issued guidance for the third cycle, teeing up another 15 drugs to be selected by early next year.

182
182
article thumbnail

Introducing my Substack newsletter Digital Pharma Insight

Dominic Tyer

Now that Ive started taking on freelance clients for editorial work the one piece missing from my time online feels like it’s something thats dedicated to digital pharma.

Pharma 130
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

UK trumpets a trade deal with India - but pharma isn't happy

pharmaphorum

Various industries have welcomed news of a trade deal between the UK and India, but Britain's pharma sector isn't among them

Pharma 101
article thumbnail

AviadoBio opens UK trial for FTD gene therapy

PharmaTimes

Aspire-FTD study aims to stop disease progression with one-time treatment

105
105
article thumbnail

FDA awards cancer drug approvals to AbbVie and MSD

Pharmaceutical Technology

The FDA has approved MSDs Welireg for rare adrenal tumours, and AbbVies Emrelis for treating c-Met+ lung cancer patients.

FDA 110
article thumbnail

Innovate or Stagnate: Overcoming Model Governance Challenges in Life Sciences

MedCity News

By treating model governance as a proactive, integral part of operations rather than a box to check after the fact, life sciences organizations can uphold compliance, better allocate their resources, and gain a competitive edge. The post Innovate or Stagnate: Overcoming Model Governance Challenges in Life Sciences appeared first on MedCity News.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

With TV ads under threat, here’s how pharma can leverage social media

PharmaVoice

RFK Jr.’s plan to ban TV advertising may shift more marketing attention to online platforms.

Media 182
article thumbnail

List of Drug patent expiration 2025

Pharmatutor

List of Drug patent expiration 2025 admin Fri, 05/02/2025 - 14:05 Drug patent expiration presents a significant opportunity for the launch of generic medications, which can dramatically alter market dynamics. When a branded drug's patent expires, it opens the door for generic manufacturers to produce and sell bioequivalent versions at a lower cost, leading to increased competition and reduced prices.

article thumbnail

Shionogi aims to buy tobacco giant's pharma unit for $1bn

pharmaphorum

Shionogi has reached a $1.

Pharma 93